ELAN vs RJF · rev $2.74B vs rev $15.91B
Elanco Animal Health (ELAN) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
Elanco Animal Health (ELAN) is a drug manufacturers - specialty & generic company listed on US.
RJF (RJF) common stock.
Latest reported ELAN revenue for 2026-06-30 was $2.74B. Net income was $111.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. ELAN currently screens at market cap $11.80B.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
ELAN currently screens at market cap $11.80B. RJF currently screens at market cap $0.
Not investment advice. Open the ELAN and RJF stock pages for the full models.
Not investment advice.